| Nicole Benderoth, RN | |
|
925 Bear Corbitt Rd, Bear, DE 19701-1323 | |
| (302) 454-2400 | |
| (302) 454-5440 |
| Full Name | Nicole Benderoth |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - School |
| Location | 925 Bear Corbitt Rd, Bear, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831636562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | L1-0028818 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Benderoth, RN 925 Bear Corbitt Rd, Bear, DE 19701-1323 Ph: (302) 454-2400 | Nicole Benderoth, RN 925 Bear Corbitt Rd, Bear, DE 19701-1323 Ph: (302) 454-2400 |
News Archive
Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the use of inhaled nitric oxide (iNO) with the INOpulse DS drug-delivery system as a combination product for pulmonary arterial hypertension.
ViraShield, the new UV sanitizer introduced by VirWall Systems Inc., is the first multi-purpose device of its kind that takes only seconds to rid those products we've come to depend on of the bacteria and viruses that typically crawl, breed and cover the surfaces of our personal communications devices.
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
As the Obama Administration seizes on a proposed 39-percent rate hike by a California insurer earlier this month to rally new support for a health overhaul, that insurer's top executive is preparing to go before Congress, The Associated Press/Los Angeles Times reports.
In the online March 2006 version of Cancer, Dr. Kawakami and associates report from the CaPSURE database that primary androgen deprivation therapy (PADT) is used in 14% of prostate cancer (CaP) patients with reasonable outcomes at approximately 5 years follow-up.
› Verified 5 days ago
Ann Marie Kaiser, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 925 Bear Corbitt Rd, Bear, DE 19701 Phone: 302-454-2400 | |
Susan Webber, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 925 Bear Corbitt Rd, Bear, DE 19701 Phone: 302-454-2400 | |
Sharon Urban, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Bernice Dr, Bear, DE 19701 Phone: 302-354-4802 | |
Alfred Wedel, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 925 Bear Corbitt Rd, Bear, DE 19701 Phone: 302-454-2400 Fax: 302-454-5440 | |
Caren M Dibattista, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 925 Bear Corbitt Rd, Bear, DE 19701 Phone: 302-454-2400 Fax: 302-454-5440 | |
Mrs. Brittany Marie Gee, CNM, RN-BSN Registered Nurse Medicare: Medicare Enrolled Practice Location: 404 Foxhunt Dr, Bear, DE 19701 Phone: 302-836-2864 | |
Tiffany Ford, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 925 Bear Corbitt Rd, Bear, DE 19701 Phone: 302-454-2400 Fax: 302-454-5442 |